ABC12: New drug kills metastatic melanoma
UC research looks at new drug that could improve treatments for metastatic melanoma
Doctors can often detect and treat early-stage melanoma, but when it advances, it is much tougher to fight and is fatal nearly half the time. Now a team of scientists at the University of Cincinnati is developing a combination therapy that can improve existing melanoma treatments.
Years of sun exposure or other UV light is a risk factor for melanoma, which can be deadly if not caught early.
“Melanoma, eventually, tends to go to the brain,” described Soma Sengupta, MD, PhD, a neuro-oncologist at the University of Cincinnati and UC Health.
“When it goes to the brain, it’s extremely challenging to treat,” explained Daniel Pomeranz Krummel, PhD, a researcher at the University of Cincinnati.
Read more about this research on UC News.
Featured photo of Pomeranz Krummel and Sengupta in their lab by Joe Fuqua/UC Creative + Brand.
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up to date on all UC's COVID-19 stories, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Thrilled with their match
March 18, 2024
UC College of Medicine students celebrated Match Day on March 15, 2024.
WCPO: Settlement could lead to lower home prices
March 18, 2024
It could become more affordable to buy a house, a University of Cincinnati professor told WCPO, after the National Association of Realtors reached a settlement that is expected to lower agent commissions.
WCPO: Cincinnati a hub for stroke research
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.